Current filters:


Popular Filters

1026 to 1050 of 1151 results

Tanzania aims to double domestic drug production


Local pharma manufacturers in Tanzania have targeted increasing production capacity by 50% by 2015 hoping…

FinancialGenericsMarkets & MarketingPharmaceuticalRest of the World

European generics trade group urges addressing medicines affordability and availability risks


With pensioners set to represent over 60% of the working population by 2060 in Europe, the pharmaceutical…


Australian medicines could lead the way for manufacturing in the "Asian century"


If supported by good public policy, medicines could play a significant role in ensuring Australia adapts…

Asia-PacificGenericsMarkets & MarketingPatentsRegulation

Teva launches copy version of Difflam in the UK


The UK subsidiary of Israeli generics giant Teva Pharmaceutical Industries (Nadaq: TEVA) has announced…

DifflamEuropeGenericsMarkets & MarketingMeda PharmaceuticalsNeurologicalOroezeTeva Pharmaceutical Industries

Australia's PIC reports to Ministers on treatment and reimbursement of similar biologics


The Australian Pharmaceuticals Industry Council (PIC), with industry group members AusBiotech, Medicines…


Lilly to increase equity position in China's Novast by $20 million


US pharma major Eli Lilly (NYSE: LLY) says it will increase of its network of manufacturing capabilities…

Asia-PacificEli LillyGenericsMergers & AcquisitionsNovast LaboratoriesPharmaceutical

UBICHEM Group adds new large scale manufacturing site in Hungary


Independent UK company UBICHEM Group has announced further growth of its business by adding a new manufacturing…

EuropeFinancialGenericsPharmaceuticalUBICHEM Group

Forest Labs cuts FY 2013 earnings forecasts on Lexapro woes


Following the expiration of US drugmaker Forest Laboratories' (NYSE: FRX) once best-selling anxiety drug…

FinancialForest LaboratoriesGenericsLevothroidLexaproPharmaceutical

Mylan settles Provigil litigation with Teva


US generic major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Pharmaceuticals has resolved all…

CephalonFinancialGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaProvigilTeva Pharmaceutical Industries

Call for harmonization of new drug standards in East Africa


Speaking at a five-day workshop in Dar es Salaam last week, East Africa Community (EAC) members states…

GenericsPharmaceuticalRegulationRest of the World

Indonesian $16 million NSCLC drugs market kept afloat by high-priced branded drugs


Branded drugs for the treatment of non-small cell lung cancer (NSCLC) in Indonesia cost almost three…

Asia-PacificGenericsHealthcareMarkets & MarketingOncologyPharmaceutical

Merck KGaA collaborates with Dr Reddy's on biosimilars


With the aim of capitalizing on the batch of patent expires for blockbuster biotechnology-based drugs…

BiotechnologyDr Reddy's LaboratoriesGenericsMarkets & MarketingMerck KGaAMerck SeronoOncologyResearch

No observable difference between generic and branded statins in preventing CV events; study


People taking the most commonly used generic and branded statins to control their cholesterol had similar…

Cardio-vascularGenericsNorth AmericaPharmaceuticalPricing

Hi-Tech Pharmacal gains rights to the Cormax brand from Watson


Hi-Tech Pharmacal (Nasdaq: HITK) says it has signed a definitive agreement under which it has acquired…

CormaxDermatologicalsGenericsHi-Tech PharmacalLicensingWatson Pharmaceuticals

US House of Reps Passes FDA Reform Act


Just days after the US Senate overwhelming approved the Food and Drug Administration Safety and Innovation…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

UCB buys majority stake in local drugmaker to expand in Brazil


Belgium's leading pharma company UCB (Euronext Brussels: UCB) says it has signed an agreement to acquire…

GenericsMeizler BiopharmaMergers & AcquisitionsPharmaceuticalSouth AmericaUCB

Problems facing Indonesia's pharma sector


Environmentally, Indonesia is particularly prone to natural disasters, as the recent earthquakes, tsunamis…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceuticalPricing

Stada Arz sales companies do well in German generics market tenders


The executive board of German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) believes that…

EuropeFinancialGenericsMarkets & MarketingSTADA Arzneimittel

Patent losses will drive generics in cardiovascular diseases market to 2018


The global generics market cardiovascular drugs is expected to grow rapidly due to the growing dyslipdemia,…

Cardio-vascularGenericsMarkets & MarketingPatents

1026 to 1050 of 1151 results



Back to top